BPA for ruzurgi
Ended Awarded Last action
- Contract number
- 36E79720A0017
- Awardee
-
Jacobus Pharmaceutical CO. Inc. UEI G63QWAN3DLR3
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 100% complete
- IDV ceiling
- $1,313,825.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Blanket Purchase Agreement was awarded by the Department of Veterans Affairs National Acquisition Center to Jacobus Pharmaceutical CO. Inc. for the procurement of pharmaceuticals and drugs under GSA Schedule FSS-61-IB. With a potential value of $1,313,825, the single award BPA has a period of performance through June 22, 2022 to acquire Ruzurgi for the VA.
The original solicitation sought a contractor under GSA Schedule FSS-61-IB Pharmaceuticals and Drugs to provide Ruzurgi, an anti-cancer medication, on an as-needed basis to various VA medical centers. Jacobus Pharmaceutical was selected as the prime contractor in August 2020 to supply Ruzurgi via the BPA for one year, with no set-aside designations applied. As the largest integrated health care system in the United States, the VA relies on BPAs like this to efficiently obtain necessary prescription medications for veterans receiving cancer treatment through the VA's extensive network of hospitals and clinics.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Legal Contract Cancellation | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79720A0017?
36E79720A0017 was awarded to Jacobus Pharmaceutical CO. Inc. by National Acquisition Center (Headquarters) on August 12, 2020.
How much is contract 36E79720A0017 worth?
36E79720A0017's own ceiling is $1,313,825.
Who can order from contract 36E79720A0017?
36E79720A0017 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79720A0017 under another contract?
Yes. 36E79720A0017 is a blanket purchase agreement under 36F79720D0098, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79720A0017 competed?
The extent of competition for 36E79720A0017 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV